Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Histological investigations on the dura mater vascular system of mice.

Mecheri B, Paris F, Lübbert H.

Acta Histochem. 2018 Nov;120(8):846-857. doi: 10.1016/j.acthis.2018.09.009. Epub 2018 Oct 4.

PMID:
30292321
2.

A randomized, intraindividual, non-inferiority, Phase III study comparing daylight photodynamic therapy with BF-200 ALA gel and MAL cream for the treatment of actinic keratosis.

Dirschka T, Ekanayake-Bohlig S, Dominicus R, Aschoff R, Herrera-Ceballos E, Botella-Estrada R, Hunfeld A, Kremser M, Schmitz B, Lübbert H, Puig S.

J Eur Acad Dermatol Venereol. 2019 Feb;33(2):288-297. doi: 10.1111/jdv.15185. Epub 2018 Aug 14.

3.

A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF-200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy.

Morton CA, Dominicus R, Radny P, Dirschka T, Hauschild A, Reinhold U, Aschoff R, Ulrich M, Keohane S, Ekanayake-Bohlig S, Ibbotson S, Ostendorf R, Berking C, Gröne D, Schulze HJ, Ockenfels HM, Jasnoch V, Kurzen H, Sebastian M, Stege H, Staubach P, Gupta G, Hübinger F, Ziabreva I, Schmitz B, Gertzmann A, Lübbert H, Szeimies RM.

Br J Dermatol. 2018 Aug;179(2):309-319. doi: 10.1111/bjd.16441. Epub 2018 May 16.

PMID:
29432644
4.

The influence of different illumination parameters on protoporphyrin IX induced cell death in squamous cell carcinoma cells.

Novak B, Heesen L, Schary N, Lübbert H.

Photodiagnosis Photodyn Ther. 2018 Mar;21:385-392. doi: 10.1016/j.pdpdt.2018.02.007. Epub 2018 Feb 7.

5.

Patient-reported health outcomes in patients with non-melanoma skin cancer and actinic keratosis: results from a large-scale observational study analysing effects of diagnoses and disease progression.

Philipp-Dormston WG, Müller K, Novak B, Strömer K, Termeer C, Hammann U, Glutsch JW, Krähn-Senftleben G, Lübbert H, Koller M, Szeimies RM; NMSC-QoL Study Group.

J Eur Acad Dermatol Venereol. 2018 Jul;32(7):1138-1146. doi: 10.1111/jdv.14703. Epub 2018 Jan 12.

6.

Helional-induced activation of human olfactory receptor 2J3 promotes apoptosis and inhibits proliferation in a non-small-cell lung cancer cell line.

Kalbe B, Schulz VM, Schlimm M, Philippou S, Jovancevic N, Jansen F, Scholz P, Lübbert H, Jarocki M, Faissner A, Hecker E, Veitinger S, Tsai T, Osterloh S, Hatt H.

Eur J Cell Biol. 2017 Jan;96(1):34-46. doi: 10.1016/j.ejcb.2016.11.004. Epub 2016 Dec 5.

PMID:
27939274
7.

Olfactory Receptors Modulate Physiological Processes in Human Airway Smooth Muscle Cells.

Kalbe B, Knobloch J, Schulz VM, Wecker C, Schlimm M, Scholz P, Jansen F, Stoelben E, Philippou S, Hecker E, Lübbert H, Koch A, Hatt H, Osterloh S.

Front Physiol. 2016 Aug 4;7:339. doi: 10.3389/fphys.2016.00339. eCollection 2016.

8.

A randomized, double-blind, phase III, multicentre study to evaluate the safety and efficacy of BF-200 ALA (Ameluz(®) ) vs. placebo in the field-directed treatment of mild-to-moderate actinic keratosis with photodynamic therapy (PDT) when using the BF-RhodoLED(®) lamp.

Reinhold U, Dirschka T, Ostendorf R, Aschoff R, Berking C, Philipp-Dormston WG, Hahn S, Lau K, Jäger A, Schmitz B, Lübbert H, Szeimies RM.

Br J Dermatol. 2016 Oct;175(4):696-705. doi: 10.1111/bjd.14498. Epub 2016 Jun 25.

PMID:
26921093
9.

Hypoxia facilitates neurogenic dural plasma protein extravasation in mice: a novel animal model for migraine pathophysiology.

Hunfeld A, Segelcke D, Bäcker I, Mecheri B, Hemmer K, Dlugosch E, Andriske M, Paris F, Zhu X, Lübbert H.

Sci Rep. 2015 Dec 8;5:17845. doi: 10.1038/srep17845.

10.

BF-1--a novel selective 5-HT2B receptor antagonist blocking neurogenic dural plasma protein extravasation in guinea pigs.

Schmitz B, Ullmer C, Segelcke D, Gwarek M, Zhu XR, Lübbert H.

Eur J Pharmacol. 2015 Mar 15;751:73-80. doi: 10.1016/j.ejphar.2015.01.043. Epub 2015 Feb 7.

PMID:
25666387
11.

Olfaction in three genetic and two MPTP-induced Parkinson's disease mouse models.

Kurtenbach S, Wewering S, Hatt H, Neuhaus EM, Lübbert H.

PLoS One. 2013 Oct 30;8(10):e77509. doi: 10.1371/journal.pone.0077509. eCollection 2013.

12.

Synaptic adhesion molecules in Cadm family at the neuromuscular junction.

Tanabe Y, Fujita E, Hayashi YK, Zhu X, Lubbert H, Mezaki Y, Senoo H, Momoi T.

Cell Biol Int. 2013 Jul;37(7):731-6. doi: 10.1002/cbin.10092. Epub 2013 Apr 18.

PMID:
23505055
13.

Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Hahn S, Pabst G, Voss D, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group; AK-CT003 Study Group.

Br J Dermatol. 2013 Apr;168(4):825-36. doi: 10.1111/bjd.12158.

14.

Comparison of the uptake of 5-aminolevulinic acid and its methyl ester in keratinocytes and skin.

Schulten R, Novak B, Schmitz B, Lübbert H.

Naunyn Schmiedebergs Arch Pharmacol. 2012 Oct;385(10):969-79. doi: 10.1007/s00210-012-0777-4. Epub 2012 Jul 17.

PMID:
22801976
15.

δ-Aminolevulinic acid and its methyl ester induce the formation of Protoporphyrin IX in cultured sensory neurones.

Novak B, Schulten R, Lübbert H.

Naunyn Schmiedebergs Arch Pharmacol. 2011 Dec;384(6):583-602. doi: 10.1007/s00210-011-0683-1. Epub 2011 Sep 25.

PMID:
21947250
16.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo.

Dirschka T, Radny P, Dominicus R, Mensing H, Brüning H, Jenne L, Karl L, Sebastian M, Oster-Schmidt C, Klövekorn W, Reinhold U, Tanner M, Gröne D, Deichmann M, Simon M, Hübinger F, Hofbauer G, Krähn-Senftleben G, Borrosch F, Reich K, Berking C, Wolf P, Lehmann P, Moers-Carpi M, Hönigsmann H, Wernicke-Panten K, Helwig C, Foguet M, Schmitz B, Lübbert H, Szeimies RM; AK-CT002 Study Group.

Br J Dermatol. 2012 Jan;166(1):137-46. doi: 10.1111/j.1365-2133.2011.10613.x. Epub 2011 Dec 21.

PMID:
21910711
17.

GABAA receptors involved in sleep and anaesthesia: β1- versus β3-containing assemblies.

Yanovsky Y, Schubring S, Fleischer W, Gisselmann G, Zhu XR, Lübbert H, Hatt H, Rudolph U, Haas HL, Sergeeva OA.

Pflugers Arch. 2012 Jan;463(1):187-99. doi: 10.1007/s00424-011-0988-4. Epub 2011 Jul 7.

PMID:
21735059
18.

Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.

Schmidt S, Linnartz B, Mendritzki S, Sczepan T, Lübbert M, Stichel CC, Lübbert H.

Hum Mol Genet. 2011 Mar 15;20(6):1197-211. doi: 10.1093/hmg/ddq564. Epub 2011 Jan 6.

PMID:
21212098
19.

Spinal cord pathology in alpha-synuclein transgenic mice.

Mendritzki S, Schmidt S, Sczepan T, Zhu XR, Segelcke D, Lübbert H.

Parkinsons Dis. 2010 Jul 8;2010:375462. doi: 10.4061/2010/375462.

20.

Parkin directly modulates 26S proteasome activity.

Um JW, Im E, Lee HJ, Min B, Yoo L, Yoo J, Lübbert H, Stichel-Gunkel C, Cho HS, Yoon JB, Chung KC.

J Neurosci. 2010 Sep 1;30(35):11805-14. doi: 10.1523/JNEUROSCI.2862-09.2010.

21.

Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a prospective, randomized, double-blind, placebo-controlled phase III study.

Szeimies RM, Radny P, Sebastian M, Borrosch F, Dirschka T, Krähn-Senftleben G, Reich K, Pabst G, Voss D, Foguet M, Gahlmann R, Lübbert H, Reinhold U.

Br J Dermatol. 2010 Aug;163(2):386-94. doi: 10.1111/j.1365-2133.2010.09873.x. Epub 2010 May 28.

PMID:
20518784
22.

Fragrant dioxane derivatives identify beta1-subunit-containing GABAA receptors.

Sergeeva OA, Kletke O, Kragler A, Poppek A, Fleischer W, Schubring SR, Görg B, Haas HL, Zhu XR, Lübbert H, Gisselmann G, Hatt H.

J Biol Chem. 2010 Jul 30;285(31):23985-93. doi: 10.1074/jbc.M110.103309. Epub 2010 May 28.

23.

Incidence of polycystic ovaries and androgen serum levels in women with borderline personality disorder.

Roepke S, Ziegenhorn A, Kronsbein J, Merkl A, Bahri S, Lange J, Lübbert H, Schweiger U, Heuser I, Lammers CH.

J Psychiatr Res. 2010 Oct;44(13):847-52. doi: 10.1016/j.jpsychires.2010.01.007. Epub 2010 Feb 10.

PMID:
20149393
24.

Upregulation of cathepsin S in psoriatic keratinocytes.

Schönefuss A, Wendt W, Schattling B, Schulten R, Hoffmann K, Stuecker M, Tigges C, Lübbert H, Stichel C.

Exp Dermatol. 2010 Aug;19(8):e80-8. doi: 10.1111/j.1600-0625.2009.00990.x.

25.

Intra- versus extracellular effects of microglia-derived cysteine proteases in a conditioned medium transfer model.

Wendt W, Schulten R, Stichel CC, Lübbert H.

J Neurochem. 2009 Sep;110(6):1931-41. doi: 10.1111/j.1471-4159.2009.06283.x. Epub 2009 Jul 17.

26.

Molecular interaction between parkin and PINK1 in mammalian neuronal cells.

Um JW, Stichel-Gunkel C, Lübbert H, Lee G, Chung KC.

Mol Cell Neurosci. 2009 Apr;40(4):421-32. doi: 10.1016/j.mcn.2008.12.010. Epub 2009 Jan 8.

PMID:
19167501
27.

Analgesic and antiinflammatory effects of cannabinoid receptor agonists in a rat model of neuropathic pain.

Leichsenring A, Andriske M, Bäcker I, Stichel CC, Lübbert H.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Jun;379(6):627-36. doi: 10.1007/s00210-008-0386-4. Epub 2009 Jan 18.

PMID:
19152053
28.

The in vitro receptor profile of rotigotine: a new agent for the treatment of Parkinson's disease.

Scheller D, Ullmer C, Berkels R, Gwarek M, Lübbert H.

Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):73-86. doi: 10.1007/s00210-008-0341-4. Epub 2008 Aug 14.

PMID:
18704368
29.

Differential expression of Cathepsin S and X in the spinal cord of a rat neuropathic pain model.

Leichsenring A, Bäcker I, Wendt W, Andriske M, Schmitz B, Stichel CC, Lübbert H.

BMC Neurosci. 2008 Aug 12;9:80. doi: 10.1186/1471-2202-9-80.

30.

Upregulation of cathepsin S in the aging and pathological nervous system of mice.

Wendt W, Lübbert H, Stichel CC.

Brain Res. 2008 Sep 26;1232:7-20. doi: 10.1016/j.brainres.2008.07.067. Epub 2008 Jul 29.

PMID:
18694734
31.

The neuronal RhoA GEF, Tech, interacts with the synaptic multi-PDZ-domain-containing protein, MUPP1.

Estévez MA, Henderson JA, Ahn D, Zhu XR, Poschmann G, Lübbert H, Marx R, Baraban JM.

J Neurochem. 2008 Aug;106(3):1287-97. doi: 10.1111/j.1471-4159.2008.05472.x. Epub 2008 Jun 4.

32.

Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease.

Scheller D, Stichel-Gunkel C, Lübbert H, Porras G, Ravenscroft P, Hill M, Bezard E.

Neurosci Lett. 2008 Feb 13;432(1):30-4. Epub 2007 Dec 8.

PMID:
18162314
33.

Non-motor behavioural impairments in parkin-deficient mice.

Zhu XR, Maskri L, Herold C, Bader V, Stichel CC, Güntürkün O, Lübbert H.

Eur J Neurosci. 2007 Oct;26(7):1902-11. Epub 2007 Sep 20.

PMID:
17883413
34.

Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.

Stichel CC, Zhu XR, Bader V, Linnartz B, Schmidt S, Lübbert H.

Hum Mol Genet. 2007 Oct 15;16(20):2377-93. Epub 2007 Apr 5.

PMID:
17412759
35.

Differential expression of cathepsin X in aging and pathological central nervous system of mice.

Wendt W, Zhu XR, Lübbert H, Stichel CC.

Exp Neurol. 2007 Apr;204(2):525-40. Epub 2007 Jan 13.

PMID:
17306794
36.

Influence of different promoters on the expression pattern of mutated human alpha-synuclein in transgenic mice.

Maskri L, Zhu X, Fritzen S, Kühn K, Ullmer C, Engels P, Andriske M, Stichel CC, Lübbert H.

Neurodegener Dis. 2004;1(6):255-65.

37.

Ascending neuropathology in the CNS of a mutant SOD1 mouse model of amyotrophic lateral sclerosis.

Leichsenring A, Linnartz B, Zhu XR, Lübbert H, Stichel CC.

Brain Res. 2006 Jun 22;1096(1):180-95. Epub 2006 Jun 5.

PMID:
16737688
38.

Sgk1, a cell survival response in neurodegenerative diseases.

Schoenebeck B, Bader V, Zhu XR, Schmitz B, Lübbert H, Stichel CC.

Mol Cell Neurosci. 2005 Oct;30(2):249-64.

PMID:
16125969
39.

Expression of DJ-1 in the adult mouse CNS.

Bader V, Ran Zhu X, Lübbert H, Stichel CC.

Brain Res. 2005 Apr 11;1041(1):102-11.

PMID:
15804505
40.

sgk1, a member of an RNA cluster associated with cell death in a model of Parkinson's disease.

Stichel CC, Schoenebeck B, Foguet M, Siebertz B, Bader V, Zhu XR, Lübbert H.

Eur J Neurosci. 2005 Jan;21(2):301-16.

PMID:
15673431
41.

Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer.

Schwarz C, Lübbert H, Rahn W, Schönfeld N, Serke M, Loddenkemper R.

Eur Respir J. 2004 Nov;24(5):728-30.

42.

Impairment of the antiproliferative effect of glucocorticosteroids by 11beta-hydroxysteroid dehydrogenase type 2 overexpression in MCF-7 breast-cancer cells.

Lipka C, Mankertz J, Fromm M, Lübbert H, Bühler H, Kühn W, Ragosch V, Hundertmark S.

Horm Metab Res. 2004 Jul;36(7):437-44.

PMID:
15305225
43.

Parkin expression in the developing mouse.

Kühn K, Zhu XR, Lübbert H, Stichel CC.

Brain Res Dev Brain Res. 2004 Apr 19;149(2):131-42.

PMID:
15063093
44.

Galantamine is an allosterically potentiating ligand of neuronal nicotinic but not of muscarinic acetylcholine receptors.

Samochocki M, Höffle A, Fehrenbacher A, Jostock R, Ludwig J, Christner C, Radina M, Zerlin M, Ullmer C, Pereira EF, Lübbert H, Albuquerque EX, Maelicke A.

J Pharmacol Exp Ther. 2003 Jun;305(3):1024-36. Epub 2003 Mar 20.

PMID:
12649296
45.

The mouse MPTP model: gene expression changes in dopaminergic neurons.

Kühn K, Wellen J, Link N, Maskri L, Lübbert H, Stichel CC.

Eur J Neurosci. 2003 Jan;17(1):1-12.

PMID:
12534964
46.

Antagonist effect of pseudohypericin at CRF1 receptors.

Simmen U, Bobirnac I, Ullmer C, Lübbert H, Berger Büter K, Schaffner W, Schoeffter P.

Eur J Pharmacol. 2003 Jan 5;458(3):251-6.

PMID:
12504780
47.

DEPD, a high resolution gene expression profiling technique capable of identifying new drug targets in the central nervous system.

Maelicke A, Lübbert H.

J Recept Signal Transduct Res. 2002 Feb-Nov;22(1-4):283-95. Review.

PMID:
12503622
48.

Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1.

Becamel C, Figge A, Poliak S, Dumuis A, Peles E, Bockaert J, Lubbert H, Ullmer C.

J Biol Chem. 2001 Apr 20;276(16):12974-82. Epub 2001 Jan 9.

49.

Parkin expression in the adult mouse brain.

Stichel CC, Augustin M, Kühn K, Zhu XR, Engels P, Ullmer C, Lübbert H.

Eur J Neurosci. 2000 Dec;12(12):4181-94.

PMID:
11122330
50.

Serum leptin levels, body fat deposition, and weight in females with anorexia or bulimia nervosa.

Mathiak K, Gowin W, Hebebrand J, Ziegler A, Blum WF, Felsenberg D, Lübbert H, Köpp W.

Horm Metab Res. 1999 Apr;31(4):274-7.

PMID:
10333084

Supplemental Content

Loading ...
Support Center